As of September 2024, Shenzhen Hepalink Pharmaceutical Group has a market cap of $1.71B. This makes Shenzhen Hepalink Pharmaceutical Group the world's 5666th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $1.53B | -25.40% |
2023 | $2.05B | -8.72% |
2022 | $2.25B | -24.85% |
2021 | $3.00B | -0.70% |
2020 | $3.02B | -11.74% |
2019 | $3.42B | -15.36% |
2018 | $4.04B | 50.85% |
2017 | $2.68B | -16.14% |
2016 | $3.19B | -17.58% |
2015 | $3.87B | 37.09% |
2014 | $2.82B | 27.09% |
2013 | $2.22B | 8.27% |
2012 | $2.05B | -24.09% |
2011 | $2.70B | -64.49% |
2010 | $7.62B | - |